A newspaper columnist recently suggested on social media that responding to the pandemic with a lockdown does not […]
Strategic research agreement announced with Milton Keynes University Hospital Foundation Trust
Investigational oral treatment is being investigated in C3 glomerulopathy
Drug authorised for use in non-metastatic castration-resistant prostate cancer
Trial was paused in September following participant illness
Updated Date: Mon, 19 Oct 2020 00:00:00 EDT
Updated Date: Mon, 19 Oct 2020 00:00:00 EDT
Updated Date: Mon, 19 Oct 2020 00:00:00 EDT
Updated Date: Mon, 19 Oct 2020 00:00:00 EDT
Updated Date: Mon, 19 Oct 2020 00:00:00 EDT